Yafei Liu
Wuhan University(CN)Renmin Hospital of Wuhan University(CN)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Gut microbiota and health, Clostridium difficile and Clostridium perfringens research, Animal Virus Infections Studies
Most-Cited Works
- → An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies(2021)286 cited
- → Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening(2020)243 cited
- → The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance(2021)196 cited
- → SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies(2022)105 cited
- → SARS-CoV-2 Lambda variant exhibits higher infectivity and immune resistance(2021)97 cited
- → Rescue fecal microbiota transplantation for antibiotic-associated diarrhea in critically ill patients(2019)81 cited
- → The N-terminal domain of spike glycoprotein mediates SARS-CoV-2 infection by associating with L-SIGN and DC-SIGN(2020)72 cited
- → Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults: randomized, double-blind, and placebo-controlled phase 1 and phase 2 clinical trials(2021)64 cited
- → Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes(2020)47 cited
- → The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines(2021)38 cited